| Literature DB >> 28122242 |
Yunjong Lee1, Daniel A Stevens2, Sung-Ung Kang3, Haisong Jiang3, Yun-Il Lee4, Han Seok Ko3, Leslie A Scarffe2, George E Umanah4, Hojin Kang5, Sangwoo Ham5, Tae-In Kam4, Kathleen Allen3, Saurav Brahmachari6, Jungwoo Wren Kim7, Stewart Neifert3, Seung Pil Yun4, Fabienne C Fiesel8, Wolfdieter Springer8, Valina L Dawson9, Joo-Ho Shin10, Ted M Dawson11.
Abstract
Mutations in PTEN-induced putative kinase 1 (PINK1) and parkin cause autosomal-recessive Parkinson's disease through a common pathway involving mitochondrial quality control. Parkin inactivation leads to accumulation of the parkin interacting substrate (PARIS, ZNF746) that plays an important role in dopamine cell loss through repression of proliferator-activated receptor gamma coactivator-1-alpha (PGC-1α) promoter activity. Here, we show that PARIS links PINK1 and parkin in a common pathway that regulates dopaminergic neuron survival. PINK1 interacts with and phosphorylates serines 322 and 613 of PARIS to control its ubiquitination and clearance by parkin. PINK1 phosphorylation of PARIS alleviates PARIS toxicity, as well as repression of PGC-1α promoter activity. Conditional knockdown of PINK1 in adult mouse brains leads to a progressive loss of dopaminergic neurons in the substantia nigra that is dependent on PARIS. Altogether, these results uncover a function of PINK1 to direct parkin-PARIS-regulated PGC-1α expression and dopaminergic neuronal survival.Entities:
Keywords: PARIS; PGC-1α; PINK1; Parkinson’s disease; ZNF746; parkin; ubiquitin
Mesh:
Substances:
Year: 2017 PMID: 28122242 PMCID: PMC5312976 DOI: 10.1016/j.celrep.2016.12.090
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423